Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Sanofi Aventis
Scientific Title
A Phase 1/2 Non-randomized, Open-label, Multi-cohort, Multi-center Study Assessing the Clinical Benefit of SAR444245 (THOR- 707) Combined With Cemiplimab for the Treatment of Participants With Advanced Unresectable or Metastatic Skin Cancers